S-DUAL

Serial Number 79365471
686

Registration Progress

Application Filed
Jan 31, 2023
Under Examination
Approved for Publication
Jun 17, 2025
Published for Opposition
Jun 17, 2025
Registered

Trademark Image

S-DUAL

Basic Information

Serial Number
79365471
Filing Date
January 31, 2023
Published for Opposition
June 17, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 17, 2025
Application
Pending
Classes
001 005 042

Rights Holder

Samsung Biologics Co., Ltd.

03
Address
300, Songdo bio-daero,
Yeonsu-gu Incheon
KR

Ownership History

Samsung Biologics Co., Ltd.

Original Applicant
03
KR

Samsung Biologics Co., Ltd.

Owner at Publication
03
KR

Legal Representation

Attorney
Brian P. Gregg

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Jun 17, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 17, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 11, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 16, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 15, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 15, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 15, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 15, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 6, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 31, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Aug 14, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Aug 14, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 20, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
May 20, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
May 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 20, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
May 16, 2024 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
May 16, 2024 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
May 16, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Nov 22, 2023 RFNP P REFUSAL PROCESSED BY IB Loading...
Nov 2, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 2, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 2, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 1, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 16, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Multiple fusion proteins in raw material form for scientific or medical research use; diagnostic reagents for scientific or research use; enzymes for scientific or research purposes; bispecific antibody being monoclonal antibodies for in vitro scientific or medical research use; cell culture reagents for scientific and research use; monoclonal antibodies for in vitro scientific purposes; microorganisms for scientific or laboratory purposes, other than for medical and veterinary use; biological preparations for scientific or industrial laboratory purposes; fusion proteins in raw material form for scientific or medical research laboratory purposes; polymerase for nucleic acid for scientific or laboratory purposes; biochemical preparations for scientific purposes; double antibody reagents for scientific purposes; double antibody reagents for scientific purposes in biotechnological product development; biological preparations for use in biotechnology, other than for medical and veterinary use; biochemical catalysts; chemical reagents for use in genetic research for non-medical purposes
Class 005
Reagents for measurement of HBs antibody for medical purposes; crude medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for activating cellular function; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating ocular diseases; chemical preparations for use in DNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for medical or veterinary purposes, namely, for bispecific or multispecific antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, neurological disorder and for related diagnostic or therapeutic use, and for use in related assays; biotechnological preparations being reagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical use, namely, for bispecific or multispecific antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, neurological disorder and for related diagnostic or therapeutic use, and for use in related assays; reagents for medical use; reagent paper for medical purposes; bispecific colostral antibody for medical purposes; medical diagnostic test strips for use in the field of blood analysis; trace element preparations for human use, namely, dietary and nutritional supplements; clinical medical reagents; therapeutic drugs for treating cancer and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; antigens being pharmaceutical preparations for stimulating immune responses; colostral antibodies for medical purposes
Class 042
Research relating to science, namely, scientific research; multiple nucleic acid scientific analysis; molecular scientific analysis; development of biotechnology; biochemical analysis; drug discovery services; new product design services; pharmaceutical research and development; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals, namely, product quality testing; fusion protein scientific analysis; computer programming services in the medical field; medical laboratories; computer project management services relating to imaging medical data; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing; providing scientific information on the testing, inspection and research of medical products; scientific laboratory services relating to the production of bispecific antibody; drug development of bispecific antibody; scientific research and development for double antibody reagent; evaluating of clinical trial progress, namely, conducting clinical trials for others; conducting clinical trials for others

Classification

International Classes
001 005 042